Sage Journals: Discover world-class research

Abstract

For decades, the advancement of cancer research has relied on in vivo models for examining key processes in cancer pathogenesis, including neoplastic transformation, progression, and response to therapy. These studies, which have traditionally relied on rodent models, have engendered a vast body of scientific literature. Recently, experimental cancer researchers have embraced many new and alternative model systems, including the zebrafish (Danio rerio). The general benefits of the zebrafish model for laboratory investigation, such as cost, size, fecundity, and generation time, were quickly superseded by the discovery that zebrafish are amenable to a wide range of investigative techniques, many of which are difficult or impossible to perform in mammalian models. These advantages, coupled with the finding that many aspects of carcinogenesis are conserved in zebrafish as compared with humans, have firmly established a unique niche for the zebrafish model in comparative cancer research. This article introduces methods for generating cancer models in zebrafish and reviews a range of models that have been developed for specific cancer types.

Keywords

animal disease models cancer genetic modification zebrafish

The zebrafish (Danio rerio) emerged as a model for scientific research in the 1930s, with many early studies devoted to the investigation of developmental processes in embryos.⁵³ The use of zebrafish in research has subsequently expanded into a broad range of disciplines. As a research species, zebrafish offer certain advantages over traditional vertebrate models, including rapid generation time, high fecundity, external embryonic development, a capacity for high stocking density in relatively small areas, and lower maintenance costs.⁶⁴ In recent years, the zebrafish has come into its own as a relevant comparative model for a diverse spectrum of human diseases.

Although zebrafish are relative newcomers to the field of comparative cancer research, these small animals have emerged as a powerful tool for investigators. As vertebrate organisms, they share many features of embryonic development and adult anatomy that are critical for comparative animal models.^64,71 In the world of cancer research, this has important implications ranging from conserved signaling pathways and transcriptional regulatory mechanisms, to organogenesis and tissue differentiation, to cellular transformation and tumor initiation. Zebrafish cancer models have been produced by a variety of methods, leading to a broad spectrum of cancer susceptibilities in animals of multiple age groups. Flexibility in genetic manipulation, adaptability to current tools for cancer analysis, and capacity to define cellular and molecular interactions in vivo provide the zebrafish with its own very unique set of advantages for the investigation of cancer biology.

Mechanisms for Developing Cancer Models in Zebrafish

Zebrafish cancer models have been developed by a number of mechanisms (Table 1). Although initial studies relied on chemical carcinogens for tumor induction,¹⁰⁵ cancer modeling in zebrafish has expanded to include numerous mutant and transgenic lines. In this setting, chemical carcinogens are often useful for identifying tumor-prone zebrafish lines from forward genetic screens^97,98 or in combination with genetic manipulation in defining a tumor susceptibility phenotype.³⁹ Although the use of forward genetic screens to develop cancer models is not typical in traditional animal models, multiple zebrafish cancer models have been successfully derived by this method.^{4,5,32,73,97,98} In some cases, this approach has identified novel genes with a previously unknown or poorly defined link to cancer susceptibility.^4,97,98

Table 1.

Methods Used to Generate Cancer Models in Zebrafish.

Approach	Rationale	Advantages	Disadvantages
Chemical carcinogenesis	Zebrafish are amenable to carcinogen-induced neoplasia	Established protocols for dosages Can accelerate tumorigenesis in mutant or transgenic models Useful to investigate potential enhancer/repressor genes	Tumor incidence is generally low Tumor induction is nonspecific and heterogeneous Potentially hazardous to researcher
Forward genetics screens	Mutations that cause severe phenotypes in homozygous embryos may enhance cancer susceptibility in heterozygous adults	Potential to discover novel cancer-associated genes May link developmental defects and cancer susceptibility	Labor intensive to maintain lines and determine mutated gene(s) Requires abundant housing space Presence of background mutations
Reverse genetics screens	Random mutagenesis can result in rare individuals with inactivating mutations in genes of interest	Recovery of specific germline mutations in genes of interest Mutations may closely resemble mutations in corresponding human genes	Initial identification of mutants can be costly and labor intensive Missense mutations may not produce a phenotype Presence of background mutations
Transgenic models	Transgenic constructs can direct gene expression to specific tissues of interest	Allows tissue-specific expression Conditional and inducible gene expression constructs are possible	Many promoters are undefined Off-target expression can occur Chemically inducible models may require separate housing
Xenotransplantation in embryos	Optically transparent embryos are ideal for examining tumor cell–stromal cell interactions in vivo	Recipient embryos do not require conditioning prior to transplant Visualization via fluorescent tagging of tumor cells and recipient stroma Large numbers of embryos can be transplanted easily	Long-term analyses are not possible Embryonic organs and systems are incompletely developed

Multiple chemical carcinogens have been studied in fish species to determine their efficacy in fish, to model human carcinogen exposure, and to assess environmental toxins.^{7,11,56,104,105} The most common routes of carcinogen exposure in zebrafish are aqueous and dietary.^{11,39,51,56,73,104,105} Additional methods used in fish species include embryo injection and topical application.^11,104 In comparison, exposure methods used in rodent models include introduction in feed or water, gastric lavage, inhalation, injection, or topical application.^43,44 Although the routes of exposure may differ in carcinogenicity studies with fish versus mammalian species, the liver is a primary target tissue for many carcinogens in both fish and rodents.^11,43,44,104

Another approach for generating cancer models in animals is through genetic manipulation. As embryonic stem cell technology is yet to be achieved in zebrafish, the generation of zebrafish lines with mutations in genes of interest has most often relied on reverse genetic screens of mutagenized zebrafish. This approach typically involves chemical or retroviral mutagenesis strategies to generate a large population of zebrafish, with each individual carrying a unique collection of randomly distributed mutations.^3,74 The offspring of each uniquely mutagenized individual can be screened for mutations in genes of interest and are used to establish a mutant line.^3,103 Mutant zebrafish lines that have been established by this method harbor mutations in important cancer susceptibility genes, including zebrafish orthologues of the human tumor suppressor genes TP53, APC, PTEN, and BRCA2, among others.^{9,24,39,85,93,99}

Creation of transgenic zebrafish lines is also possible, since 1-cell stage zebrafish embryos can be injected with plasmid or bacterial artificial chromosome (BAC) gene constructs with relative ease.^18,115 A number of technologies have been developed to increase the rate of early and efficient transgene integration.^107,108 Transgenic lines have typically relied on zebrafish promoters driving expression of human or mouse genes,^59,60,87,88 although in some cases, the zebrafish orthologue has been used succesfully.⁷⁸ The adaptation of conditional or inducible strategies for gene expression in zebrafish has greatly expanded the possibilities for genetic manipulation in this species.^37,57,63

Xenotransplantation of human or mouse cancer cells into zebrafish embryos has also proven to be a useful tool in cancer research (reviewed by Amatruda and Patton²). As zebrafish embryos do not have a fully developed immune system, conditioning of recipients is not required in these studies.⁸⁰ Because of the optical transparency of zebrafish embryos and the availability of multiple zebrafish lines that express fluorescent proteins in normal tissues, xenotransplantation experiments can allow detailed in vivo examination of cell-cell and cell-stromal interactions within the context of neoplastic cell survival, migration, and invasion.⁸⁰ Xenotransplanted zebrafish embryos also offer a high-throughput system for evaluating novel drug therapies in vivo.⁵⁴ Although further discussion of this methodology is beyond the scope of this article, the zebrafish model clearly offers a unique and diverse spectrum of approaches for the study of cancer.

Before reviewing zebrafish models for human cancer, one should be aware of nomenclature conventions for zebrafish gene names and symbols, proteins, and genotypes. Guidelines for zebrafish nomenclature are available from the Zebrafish Information Network (ZFIN), an online database for zebrafish researchers.¹⁰⁶ In brief, zebrafish gene names and gene symbols are lowercase and italicized and are named after the mammalian orthologue whenever possible. The protein symbol matches the gene symbol, but is not italicized, and begins with an uppercase letter. For mutant zebrafish lines, the mutant allele is identified by a unique line designation code that indicates the institution of origin. Transgenic lines are generally identified by “Tg,” followed by the promoter and gene construct, and a unique line designation code that indicates the institution of origin. More detailed information on zebrafish nomenclature can be found on the ZFIN website (http://zfin.org/).

Models of Cutaneous Neoplasia

A basic understanding of zebrafish skin anatomy facilitates the discussion of zebrafish models of cutaneous neoplasia. The integument of fish includes a nonkeratinized stratified squamous epidermis and underlying dermis.^71,72 Teleost species (including zebrafish) have overlapping elasmoid scales that are covered by the epidermis in the trunk region.⁷² Within the epidermis are keratinocytes, goblet cells, and alarm cells.⁷¹ Pigmented cell populations, including melanocytes, iridiphores, and xanthophores, are predominantly located in the hypodermis between the dermal stratum compactum and underlying muscle layer.⁴⁰ As in mammals, pigmented cells in fish are of neural crest origin and are designated during embryogenesis.¹³

The majority of zebrafish models for cutaneous neoplasia have focused on melanocyte-derived tumors. Multiple models for benign nevus and cutaneous melanoma exist and have been derived by targeted expression of human oncogenes in melanocytes (Table 2 and Fig. 1). Most of these models use the melanocyte-specific promoter mitfa ⁶⁶ to drive gene expression. MITF, or microphthalmia-associated transcription factor, is a critical mediator of melanocyte differentiation and survival in vertebrates and may also support survival of melanoma cells.¹¹¹ Similarly, the zebrafish orthologue of mammalian KIT is required for melanocyte migration and survival,⁸⁶ and the kita promoter also drives oncogene expression in zebrafish melanocytes.⁹⁶

Table 2.

Zebrafish Models of Cutaneous Neoplasia.

Tumor Type	Gene(s)	Methodology
Benign nevus⁸⁸	BRAF(V600E)	Zebrafish mitfa promoter-regulated expression of human BRAF(V600E)
Benign nevus²⁰	NRAS(Q61K)	Zebrafish mitfa promoter-regulated expression of human NRAS(Q61K)
Melanoma^88,110	BRAF(V600E);tp53^zdf1/zdf1	Zebrafish mitfa promoter-regulated expression of human BRAF(V600E) on tp53^zdf1 mutant background
Melanoma¹²	BRAF(V600E);mitfa^w2/w2;tp53^zdf1/zdf1 + miniCoopR-SETDB1	Zebrafish mitfa promoter-regulated expression of human BRAF(V600E) on tp53^zdf1 mutant and mitfa^w2 mutant backgrounds and injected with minCoopR-SETDB1 construct
Melanoma²⁰	NRAS(Q61K);tp53^zdf1/+	Zebrafish mitfa promoter-regulated expression of human NRAS(Q61K) on tp53^zdf1 mutant background
Melanoma²⁰	NRAS(Q61K);tp53^zdf1/zdf1
Melanoma⁷²	HRAS(G12V)	Zebrafish mitfa promoter-regulated expression of human HRAS(G12V)
Melanoma^6,96	HRAS(G12V)	Compound transgenic with zebrafish kita promoter-regulated expression of human HRAS(G12V)
Papilloma⁷	Wild-type	Immersion exposure to ENU
Epidermal tumors⁹¹	pen/lgl2	Forward screen of ENU mutagenized collection

ENU, N-ethyl-N-nitrosourea; mitfa, micropthalmia-associated transcription factor a.

Figure 1. Skin; Tg(mitfa-BRAF(V600E));tp53^zdf1/zdf1;mitfa^w2/w2 zebrafish injected with the miniCoopR construct, case No. 1. Melanoma. Neoplastic cells are generally spindeloid and infrequently contain granular brown pigment. Inset: Detail of the neoplastic cell population. Hematoxylin and eosin (HE). Figure 2. Skeletal muscle; Tg(rag2:KRAS(G12D)) zebrafish, case No. 2. Embryonal rhabdomyosarcoma. Neoplastic cells resemble stellate to spindeloid mesenchymal cells, myoblasts, or differentiating myofibers with cross striations and are accompanied by infiltrating macrophages. Inset: Detail of the neoplastic population. HE. Figure 3. Pancreas; Tg(Ptf1a:Gal4-VP16;UAS:eGFP-KRASG12V) zebrafish, case No. 3. Pancreatic ductular adenocarcinoma. Neoplastic epithelial cells form variably sized, irregularly shaped ducts within a dense fibrovascular stroma. Small clusters of acinar cells are also present. HE. Figure 4. Gill; CG1 strain zebrafish injected at the 1-cell stage with a rag2:Myc expression vector, case No. 4. Disseminated T-cell leukemia. Large numbers of neoplastic round cells with scant cytoplasm are present in the highly vascularized lamellae. HE. Figure 5. Coelom; brca2^hg5/hg5;tp53^zdf1/zdf1 zebrafish, case No. 5. Malignant peripheral nerve sheath tumor. Neoplastic cells are spindeloid and tapering, and they form haphazardly arranged fascicles and whorls. Inset: Detail of the neoplastic population. HE. Figure 6. Testis; brca2^hg5/hg5 zebrafish, case No. 6. Seminoma. Neoplastic germ cells are round to oval, exhibit large nuclei with prominent nucleoli, and form irregularly shaped clusters within tubular structures. Inset: Detail of the neoplastic population. HE.

Zebrafish models for melanoma demonstrated that expression of a mutant allele of human BRAF (BRAFV600E) or NRAS (NRASQ61K) in zebrafish melanocytes could drive formation of benign nevi in adults, but progression to melanoma required concomitant p53 mutation.^20,88 In comparison, melanoma could be induced in zebrafish without p53 mutation through targeted expression of a mutant allele of human HRAS (HRASG12V).^6,72,96 These studies converge on activation of the Ras-Raf-MEK-ERK signaling pathway, the most significant initiating event in human melanoma (reviewed by Gray-Schopfer et al³⁶). As would be expected, there is robust activation of Ras-Raf-MEK-ERK signaling in these transgenic zebrafish models.^72,88 Phosphoinositide-3-OH kinase (PI(3)K) pathway activation, also shown to be an important factor in human melanoma,³⁶ is variable in zebrafish models.^72,96 Interestingly, the role for p53 in melanoma progression is not consistent in zebrafish models, as robust p53 pathway activation was observed in melanomas from kita-GFP-HRASG12V transgenic zebrafish.⁹⁶ In human melanoma, p53 mutations are relatively rare,¹⁹ but p53 pathway inactivation is both common and critical.⁵⁰

Abnormal stripe patterning and irregular areas of cutaneous pigmentation (hyperpigmentation) are commonly observed in zebrafish models of melanoma.^20,72,88,96 Areas of aberrant pigmentation were observed in zebrafish embryos as early as 3 days postfertilization (dpf) in some models.⁹⁶ Benign nevi arise in adult zebrafish as flat, discrete to coalescing patches that are heavily pigmented, randomly distributed over the head and body, and confined to the epidermis.^20,88 In comparison, zebrafish harboring melanomas present with variably nodular masses that exhibit invasive behavior.^20,72,88,96 Although the majority of zebrafish melanomas appear heavily pigmented grossly, neoplastic cells show variable degrees of pigmentation by histology.^20,72,88,96 Zebrafish melanomas are transplantable into sublethally irradiated recipients,^20,88 although benign nevi are not.⁸⁸ Additional characterization demonstrated that zebrafish melanoma cells are highly aneuploid,⁸⁸ are highly proliferative,^72,96 and exhibit immunoreactivity for tyrosinase, Melan-A, S100, and HMB-45,⁹⁶ markers that are useful in the diagnosis of human melanoma.¹⁶

Zebrafish models of melanoma represent a powerful tool for multiple downstream experiments that delve more deeply into melanoma pathogenesis. Comparisons of microarray data from zebrafish and human melanoma samples have demonstrated similar patterns of gene expression and enrichment profiles, suggesting a similar biology among these tumors.^6,20 In a recent report, multiple candidate genes that are located in a recurrently amplified region of chromosome 1 in human melanoma were tested in a zebrafish melanoma model.¹² This study showed that overexpression of the histone methyltransferase SETDB1 significantly accelerated zebrafish melanoma formation and induced transcriptional dysregulation of multiple genes.¹² A zebrafish melanoma model has also revealed the importance of neural crest developmental pathways in melanoma formation.¹¹⁰ Through a chemical screen for small-molecule inhibitors of neural crest development in zebrafish embryos, White et al¹¹⁰ found that an inhibitor of neural crest progenitor cells could abrogate melanoma cell proliferation in vitro and in vivo.

Nonmelanoma models for cutaneous tumors in zebrafish are few (Table 2), although the convenience of this animal model for studying tumors of the skin is evident. In one study, adult zebrafish that were exposed to the mutagen N-ethyl-N-nitrosourea (ENU) developed sessile or pedunculated epidermal papillomas at 100% incidence.⁷ However, no epidermal tumors developed during a subsequent ENU carcinogenicity study in juvenile zebrafish, although tumors of other tissues were observed.¹⁰⁴ Studies with other carcinogens in zebrafish have not described the induction of cutaneous neoplasia at any significant level (summarized by Spitsbergen and Kent¹⁰⁴). The pen/lgl2 mutant zebrafish line develops aberrantly proliferative epidermal cells during embryogenesis, which form small epidermal masses when transplanted into wild-type embryos (Table 2).⁹¹ As pen/lgl2 mutants exhibit early embryonic lethality,^91,102 this line has limited use as a cancer model. Successful development of nonmelanoma models for cutaneous neoplasia in zebrafish may require a combination of techniques, such as genetic manipulation coupled with carcinogen exposure.

Models of Muscular, Adipocytic, and Vascular Neoplasia

Muscular and vascular tumors are described at low frequency in several zebrafish models with a diverse spectrum of cancer susceptibility.^48,98,105 However, there are only a small number of zebrafish models with a specific propensity for muscular, adipocytic, or vascular neoplasia (Table 3). Rhabdomyosarcoma and liposarcoma can be induced in transgenic zebrafish by targeting the Ras-Raf-MEK-ERK or PI(3)K-Akt pathways, respectively, whereas hemangiosarcoma in zebrafish is associated with haploinsufficiency for pten.^15,38,59,61

Table 3.

Zebrafish Models of Muscular, Adipocytic, and Vascular Neoplasia.

Tumor Type	Gene(s)	Methodology
Embryonal rhabdomyosarcoma⁵⁹	KRAS(G12D)	Zebrafish rag2 promoter-regulated expression of human KRAS(G12D)
Rhabdomyosarcoma⁶¹	KRAS(G12D)	Compound transgenic with conditional zebrafish β-actin promoter-regulated expression of human KRAS(G12D)
Liposarcoma³⁸	Akt2	Zebrafish rag2 promoter-regulated expression of constitutively active mouse Akt2 on tp53^zdf1 mutant background
	Akt2;tp53^zdf1/+;
	Akt2;tp53^zdf1/zdf1
Hemangiosarcoma¹⁵	ptena^hu1864/+ ;ptenb^{hu1435/hu1435}	Identified from ENU mutagenized library
Hemangiosarcoma¹⁵	ptena^{hu1864/hu1864} ;ptenb^hu1435/+	Identified from ENU mutagenized library

ENU, N-ethyl-N-nitrosourea.

The recombination activating gene-2 (RAG2) shows specific expression in mammalian lymphoid cells, although promoter activity has been observed in nonlymphoid cell populations.^81,117 In zebrafish, the rag2 promoter is expressed in both lymphoid and nonlymphoid cell populations, including mesenchymal progenitor cells.^47,59,60 Ectopic expression of the zebrafish rag2 promoter in these mesenchymal progenitor cell compartments led to development of models for rhabdomyosarcoma and liposarcoma.^38,59

Embryonal rhabdomyosarcoma developed in zebrafish that were injected at the 1-cell stage with a human KRASG12D transgene driven by the rag2 promoter (Fig. 2).⁵⁹ About 50% of mosaic transgenic zebrafish developed tumors by 80 dpf, with some animals developing masses as early as 10 dpf.⁵⁹ Histologic examination revealed undifferentiated myocytes and multinucleated cells with striations that expressed markers of myocyte differentiation, including desmin, myoD, and myogenin.⁵⁹ Serial transplantation of fluorescently labeled zebrafish rhabdomyosarcoma cells allowed isolation of a cancer stem cell population with an expression signature similar to activated satellite cells.⁵⁹ In another model, rhabdomyosarcomas were observed in 76% of compound transgenic zebrafish that expressed heat shock–inducible human KRASG12D under the zebrafish β-actin promoter.⁶¹ Similar to the prior model, these tumors were composed of small undifferentiated myocytes and striated myocytes, and they expressed desmin, myoD, and myogenin.⁶¹

In a similar approach, the zebrafish rag2 promoter driving myristoylated, constitutively active mouse Akt2 was used to develop a transgenic model for well-differentiated liposarcoma.³⁸ Although tumor incidence was low in a wild-type background, 29% of transgenic zebrafish with concomitant homozygous tp53 mutation developed liposarcomas.³⁸ Liposarcomas were composed of well-differentiated lipocytes intermixed with atypical stromal cells and lipoblasts with pleomorphic nuclei and were locally invasive.³⁸

Although rhabdomyosarcoma and liposarcoma models were developed by transgenic approaches, a model for hemangiosarcoma in zebrafish was recently described in zebrafish with germline mutations in the zebrafish orthologue of the tumor suppressor gene PTEN.¹⁵ Zebrafish have 2 copies of pten (ptena and ptenb), and 2 mutant lines carrying nonsense mutations in each gene were identified from an ENU-mutagenized library.²⁴ Interestingly, embryonic development is normal with homozygous mutation in either gene alone; however, combined homozygous mutations in ptena and ptenb result in embryonic lethality.²⁴ Adult zebrafish with haploinsufficiency for the pten genes are predisposed to hemangiosarcoma, particularly in the retrobulbar region.¹⁵ These locally invasive tumors exhibited variably sized, blood-filled spaces lined by CD31-positive neoplastic cells and were presumed to arise from the retrobulbar vascular network.¹⁵

Zebrafish models for rhabdomyosarcoma and liposarcoma have provided interesting insights into the biology of these diseases in humans. On the basis of the finding that Ras activation resulted in a high incidence of rhabdomyosarcoma in zebrafish, Langenau et al⁵⁹ compared human and zebrafish rhabdomyosarcoma by microarray analysis. These studies revealed conserved gene signatures for rhabdomyosarcoma in both species and showed that Ras pathway activation is a common feature of human rhabdomyosarcoma.⁵⁹ Similarly, the discovery that Akt activation drives liposarcoma development in zebrafish led to the finding that the Akt pathway is activated in about a third of clinical liposarcoma specimens and that inhibition of the PI(3)K-Akt-mTOR pathway in human liposarcoma cell lines impairs viability.³⁸ These findings demonstrate that zebrafish can be a useful and relevant comparative animal model for human mesenchymal tumors.

Models of Intestinal, Hepatic, and Exocrine Pancreatic Neoplasia

Although the basic structures and functions of the intestine, liver, and exocrine pancreas are similar between zebrafish and mammals, some anatomical features in zebrafish are of note. As zebrafish are agastric, the esophagus leads directly into the intestine.⁷¹ The intestine is a simple tubular structure that lacks distinguishable small and large intestinal segments, although differences can be observed in the density of goblet cells and morphology of the mucosal epithelium along its length.⁷¹ The liver is composed of 3 lobes and a gallbladder.⁷¹ Unlike mammals, hepatic cords, lobules, and portal triads are not clearly defined in the zebrafish liver, and Kupffer cells are absent.⁷¹ The pancreas in zebrafish is anatomically distinct from the liver but does not form a discrete organ.⁷¹ Clusters of exocrine pancreatic tissue are present along the intestinal tract; similar to mammals, pancreatic acini are composed of secretory cells containing bright eosinophilic granules.⁷¹

Zebrafish that are heterozygous for a germline mutation in the tumor suppressor gene adenomatous polyposis coli (apc)⁴⁵ develop intestinal, hepatic, and pancreatic tumors (Table 4).³⁹ This tumor susceptibility phenotype is similar to the familial adenomatous polyposis syndrome in humans with hereditary APC mutations (reviewed by Sieber et al¹⁰⁰), indicating a conserved role for this gene in tumors of these tissues. Although apc heterozygotes developed adenomatous intestinal polyps and hepatomas without sensitization, exposure of juvenile apc-mutant zebrafish to the carcinogen 7,12-dimethylbenz[a]anthracene (DMBA) increased the incidence of intestinal and hepatic tumors and also induced pancreatic acinar cell adenomas and biliary duct neoplasia.³⁹ Tumors from apc-mutant zebrafish showed activation of Wnt signaling, like their human counterparts, but did not exhibit loss of heterozygosity for the wild-type apc allele;³⁹ however, tumors from human patients with APC mutations typically develop biallelic APC inactivation through the acquisition of somatic mutations in the wild-type allele.¹⁰⁰ Additional studies in apc-mutant zebrafish have defined a role for retinoic acid signaling and cyclooxygenase-2 (COX-2) expression in the pathogenesis of APC-associated neoplasia²² and have been used to model a multistep progression from adenoma to carcinoma in tumors that arise in association with APC mutation.⁹⁰

Table 4.

Zebrafish Models of Intestinal, Pancreatic, and Hepatic Neoplasia.

Tumor Type	Gene(s)	Methodology
Intestinal adenoma³⁹	apc^hu745/+	Identified from ENU mutagenized library
Malignant intestinal tumors⁵¹	Multiple models	Infection with Pseudocapillaria tomentosa
Pancreatic acinar cell adenoma³⁹	apc^hu745/+	Identified from ENU mutagenized library
Pancreatic carcinoma⁸⁷	KRAS(G12V)	Zebrafish ptf1a promoter-regulated expression of human KRAS(G12V)
Pancreatic carcinoma⁶⁸	KRAS(G12V)	Compound transgenic with zebrafish ptf1a promoter-regulated expression of human KRAS(G12V)
Hepatoma³⁹	apc^hu745/+	Identified from ENU mutagenized library
Hepatocellular carcinoma⁵⁶	Wild-type	Exposure to DMBA or DBP
Hepatocellular carcinoma⁷⁸	kras(G12V)	Zebrafish fabp10a promoter-regulated expression of zebrafish kras(GV12)
Hepatocellular carcinoma⁷⁹	kras(G12V)	Compound transgenic with mifepristone-inducible and zebrafish fabp10a promoter-regulated expression of zebrafish kras(GV12)
Hepatocellular carcinoma⁶³	xmrk	Compound transgenic with tetracycline-inducible and zebrafish fabp10a promoter-regulated expression of xmrk

DBP, dibenzo[a, l]pyrene; DMBA, 7,12-dimethylbenz[a]anthracene; ENU, N-ethyl-N-nitrosourea; fabp10a, fatty acid binding protein 10a, liver basic; xmrk, mutated Xiphophorus EGFRb.

Intestinal hyperplasia, dysplasia, and neoplasia have been described at variable frequency in several other transgenic and mutant zebrafish lines,^61,73,98 as well as in zebrafish exposed to carcinogens.¹⁰⁵ Importantly, malignant intestinal neoplasia can develop in zebrafish infected with the nematode parasite Pseudocapillaria tomentosa (Table 4).⁵¹ Nematode-associated intestinal carcinomas typically arise at the esophageal-intestinal junction, often contain infiltrating inflammatory cells, and may be directly associated with adult nematodes.⁵¹ In addition to providing an interesting model for parasite- and inflammation-associated intestinal neoplasia, it is important to consider P. tomentosa infestation as a potential confounding factor in zebrafish cancer models. This parasite has been shown to promote intestinal tumorigenesis in a zebrafish carcinogenicity study.⁵¹ Although commonly found in some Florida wild-type zebrafish lines,¹⁰⁴ P. tomentosa appears to occur infrequently in today’s research colonies.

Zebrafish models for hepatic neoplasia have employed both genetic manipulation and carcinogen exposure. Carcinogens are relatively reliable for the induction of hepatic neoplasia and have been useful in defining conserved gene expression signatures in human and zebrafish hepatic tumors.^56,105 However, the lack of specificity for hepatic tumorigenesis in carcinogenesis studies and the desire for a stable and heritable cancer susceptibility phenotype have spurred the development of transgenic zebrafish models for hepatic cancer.

Several transgenic models for hepatocellular carcinoma (HCC) have been described, each using the liver-specific promoter fabp10 to drive oncogene expression (Table 4).^63,78,79 Although targeted expression of the human oncogene KRAS(G12V) resulted in variable incidence of HCC in juvenile and adult zebrafish,⁷⁸ development of a mifepristone-inducible KRAS(G12V) transgene targeted to the liver resulted in reliable induction of HCC with 100% penetrance.⁷⁹ Similarly, expression of a mutated form of EGFRb ³⁵ in the liver controlled by a tetracycline-inducible element led to a 100% incidence of HCC in juvenile and adult zebrafish.⁶³ The histologic features of HCC in these models included expansion of the liver by sheets of pleomorphic hepatocytes with prominent nucleoli, with evidence of intravascular and regional tissue invasion.^63,79 These inducible models, which show complete tumor regression upon mifepristone or tetracycline withdrawal, represent useful tools for small-molecule screens, as well as for evaluating potential enhancer/repressor genes.^63,79

A transgenic approach has also been applied for developing 2 zebrafish models for exocrine pancreatic carcinogenesis (Table 4). In both models, an eGFP-KRAS(G12V) fusion gene controlled by regulatory elements for the zebrafish pancreatic progenitor cell marker ptfa1 has been used successfully to induce pancreatic carcinoma in zebrafish.^68,87 In ptfa1a: eGFP-KRASG12V zebrafish, progenitor cells expressing the transgene undergo minimal differentiation during embryogenesis and subsequently instigate several types of malignant pancreatic neoplasia in adult zebrafish.⁸⁷ These locally invasive tumors are of both acinar and ductular origin, and they exhibit varying degrees of acinar cell differentiation, stromal expansion, and mucin production.⁸⁷ Similar to human and murine pancreatic adenocarcinomas, Hedgehog pathway activation occurred in neoplastic cells.⁸⁷ The second model is a compound transgenic zebrafish line generated with the Gal4-UAS system that targets expression of the eGFP-KRAS(G12V) fusion gene to the exocrine pancreas, leading to development of acinar and ductular pancreatic carcinoma (Figure 3).⁶⁸ This model will allow the simultaneous expression of additional candidate oncogenes in the zebrafish pancreas, facilitating the study of complex genetic interactions in pancreatic carcinogenesis.⁶⁸ The histologic and genetic similarities between human and zebrafish exocrine pancreatic tumors make this an appealing model for comparative studies.

Models of Hematopoietic and Lymphoid Neoplasia

A relatively large body of work is devoted to zebrafish models for hematopoietic and lymphoid neoplasia (Table 5), including the first report of a line of transgenic tumor-bearing zebrafish.⁶⁰ Several key anatomic and histologic differences between zebrafish and mammals are relevant for the study of these diseases. Unlike mammals, zebrafish bones do not have a medullary cavity containing hematopoietic tissue; instead, hematopoiesis occurs in the splenic stroma and renal interstitium.⁷¹ Zebrafish lack lymph nodes but do possess a thymus with cortical and medullary organization that supports lymphocytic maturation.⁷¹ Peripheral blood components include erythrocytes and thrombocytes (both nucleated in teleost species),^46,71 neutrophilic and eosinophilic granulocytes,^8,17,65 monocytes,⁷⁵ and B and T lymphocytes.^71,75 Lymphocytes are the predominant circulating leukocyte in zebrafish, representing 71% to 92% of the population.⁷⁵

Table 5.

Zebrafish Models of Hematopoietic, Lymphoid, and Small Round Blue Cell Neoplasia.

Tumor Type	Gene(s)	Methodology
T-cell leukemia⁶⁰	C-Myc	Zebrafish rag2 promoter-regulated expression of mouse C-myc
T-ALL⁵⁸	C-Myc	Conditional zebrafish rag2 promoter-regulated expression of mouse C-myc
T-ALL¹⁴	NOTCH1	Zebrafish rag2 promoter-regulated expression of truncated human NOTCH1
T-LBL and T-ALL²⁷	C-Myc	Compound transgenic line with conditional zebrafish rag2 promoter-regulated expression of mouse C-myc
T-LBL and T-ALL³²	srk, hlk, and otg mutants	Forward phenotyping screen of ENU mutagenized collection
T-ALL³⁷	MYC	Zebrafish rag2 promoter-regulated expression of human MYC fused to tamoxifen-responsive element
AML¹¹⁹	MYST3-NCOA2	Zebrafish spi1 promoter-regulated expression of human MYST3-NCOA2 fusion
Myeloproliferative neoplasm³¹	NUP98-HOXA9	Conditional zebrafish spi1 promoter-regulated expression of human NUP98-HOXA9 fusion
B-ALL⁹⁴	TEL-AML1	Xenopus elongation factor1α or zebrafish β-actin promoter regulated expression of human TEL-AML1 fusion
B-ALL⁹⁴	TEL-AML1
Small round blue cell tumors⁶²	EWS-FLI1	Zebrafish β-actin or hsp70 promoter-regulated expression of human EWS-FLI1 fusion
Small round blue cell tumors⁶²	EWS-FLI1

AML, acute myeloid leukemia; B-ALL, B-cell acute lymphocytic leukemia; ENU, N-ethyl-N-nitrosourea; spi1, spleen focus forming virus (SFFV) proviral integration oncogene spi1; T-ALL, T-cell acute lymphocytic leukemia; T-LBL, T-cell lymphoblastic lymphoma.

The majority of transgenic models for T-cell lymphoma/leukemia in zebrafish make use of the rag2 promoter, although as stated previously, this promoter can be expressed in nonlymphoid populations. Most of these models have induced neoplastic transformation in lymphoid cells via expression of the mouse or human MYC oncogene (Table 5 and Fig. 4), as overexpression of MYC or MYCN is a common feature of most human T-cell acute lymphocytic leukemia (T-ALL) subgroups.²⁹ Targeted expression of the MYC oncogene in zebrafish lymphocytes resulted in expansion of a malignant population of T lymphocytes that heavily infiltrated the thymus, kidney, and perithymic soft tissues.⁶⁰ Malignant T cells were oligoclonal, aneuploid, or hyperdiploid and were transplantable to sublethally irradiated recipients.^58,60 Additional approaches for modeling T-cell lymphoblastic lymphoma (T-LBL) and T-ALL, including the identification of several mutant lines through a forward genetic screen, have been successful (Table 5).^14,32

More complex transgenic approaches have modeled the progression from T-LBL to T-ALL in zebrafish. Use of conditional promoters in compound transgenic zebrafish have shown that zebrafish develop T-LBL, characterized by thymic enlargement and local infiltration, which progresses to T-ALL, characterized by widely disseminated disease and an abundance of malignant cells in the kidney marrow.^27,28 These types of complex genetic manipulations have permitted investigation into the mechanisms of malignant progression in zebrafish and human lymphoid neoplasia. Overexpression of the antiapoptotic gene bcl2 blocked progression from T-LBL to T-ALL in zebrafish, and malignant cells were defective in intravasation and underwent autophagy.²⁸ Further analyses of both zebrafish and human samples in this study defined molecular differences between T-LBL and T-ALL, with important implications for cell transformation, survival, and intravasation in vivo.²⁸ In another study, creation of an inducible model for T-ALL in zebrafish demonstrated the importance of the Akt pathway in accelerating tumorigenesis in combination with MYC.³⁷ A line of syngeneic zebrafish has been described that can be used for high-throughput, rapid screening of leukemic adult zebrafish, permitting the analysis of tumor-initiating cell populations in transplanted immunocompetent recipients.¹⁰¹ Zebrafish models for lymphoid malignancies thus represent a sophisticated in vivo tool for examining the mechanisms underlying transformation and disease progression.

Zebrafish are also useful in studying acute myeloid leukemia (AML), although there are fewer models for this disease (Table 5). Unlike models for T-cell malignancies, zebrafish models for AML have generally relied on the expression of human fusion genes in myeloid cells. Several of these models have demonstrated that expression of these fusion genes induces disturbances in the myeloid compartment, including redirection of progenitor cell fate from erythroid to myeloid lineage and expansion of progenitor and myeloid compartments in the marrow.^10,83,116 Transgenic zebrafish expressing the human fusion gene NUP98-HOXA9 under a heat shock–inducible promoter developed malignant myeloid cell infiltrates in multiple organs.³¹ Since zebrafish embryos develop externally, the controlled expression of NUP98-HOXA9 at certain time points during embryogenesis could be used to define specific effects on myeloid differentiation in early hematopoiesis.³¹ These and other models hold great promise for the study of myeloid malignancies in vivo.

Few other models for lymphoid or other small round cell tumors exist in zebrafish (Table 5). A single zebrafish model for B-cell acute lymphocytic leukemia (B-ALL) has been described, in which the human TEL-AML1 fusion was expressed under ubiquitous promoters.⁹⁴ Transgenic zebrafish developed lymphoblastic leukemia at low incidence, and neoplastic cells appeared to be arrested at a pre–B-cell differentiation stage.⁹⁴ In addition, a zebrafish model transgenic for the human EWS-FLI1 fusion was recently found to develop small round blue cell tumors at low incidence.⁶²

Models of Neural and Neuroendocrine Neoplasia

Tumors of the peripheral nervous system are not uncommon in zebrafish cancer models (Table 6). A number of mutant zebrafish lines develop malignant spindle cell tumors that are histologically reminiscent of malignant peripheral nerve sheath tumors (MPNSTs).^5,9,26,85,92 Curiously, these cancers arise with greatest frequency in zebrafish lines that harbor mutations in tumor suppressor genes (Table 7), suggesting that the cancer spectrum associated with these types of mutations may be more limited in zebrafish compared with humans. MPNSTs in these mutant lines typically arose in zebrafish older than 1 year.^5,9,85,92

Table 6.

Zebrafish Models of Neural and Neuroendocrine Neoplasia.

Tumor Type	Gene(s)	Methodology
MPNST⁹	tp53^zdf1/zdf1	Identified from ENU mutagenized library
MPNST²⁶	mlh1^{hu1919/hu1919}	Identified from ENU mutagenized library
MPNST²⁶	msh2^{hu1886/hu1886}	Identified from ENU mutagenized library
MPNST²⁶	msh6^{hu1811/hu1811}	Identified from ENU mutagenized library
MPNST⁵	Ribosomal protein gene mutations (multiple lines)	Forward screen of retroviral insertional mutant collection
Neuroblastoma⁴	Hagoromo mutants	Forward screen of retroviral insertional mutant collection
Neuroepithelioma²⁴	ptenb^{hu1435/hu1435}	Identified from ENU mutagenized library
Pituitary corticotroph adenoma⁶⁷	pttg	Zebrafish pomc promoter-regulated expression of zebrafish pttg
Pancreatic neuroendocrine carcinoma¹¹⁴	MYCN	Zebrafish myod promoter-regulated expression of human MYCN with human MYOD core enhancer

ENU, N-ethyl-N-nitrosourea; pomc, proopiomelanocortin; pttg, pituitary tumor transforming gene.

Table 7.

Tumor Spectrum in Humans and Zebrafish with Mutations in Tumor Suppressor Genes.

Gene	Human Cancer Spectrum^a	Zebrafish Cancer Spectrum
TP53	Li-Fraumeni syndrome⁸⁴ Breast cancer Soft tissue sarcomas Adrenocortical carcinoma Somatic mutation in sporadic cancers⁸² Ovarian cancer Colorectal cancer Esophageal cancer	MPNST and other sarcomas^9,85
MLH1 ^b MSH2 ^b MSH6 ^b	Lynch syndrome⁶⁹ Colorectal cancer Endometrial and ovarian cancer Biallelic mutation¹¹² Brain tumors Leukemia/lymphoma Lynch syndrome–associated tumors	MPNST²⁶
PTEN	Cowden syndrome²³ Breast cancer Thyroid cancer Endometrial carcinoma Somatic mutation in sporadic cancers²³ Endometrial carcinoma Glioblastoma multiforme	Neuroepithelioma²⁴ Hemangiosarcoma¹⁵
APC	Familial adenomatous polyposis syndrome²⁵ Colorectal cancer Upper gastrointestinal cancer Hepatoblastoma Somatic mutation in sporadic cancers²⁵ Colorectal cancer	Intestinal adenoma³⁹ Pancreatic adenoma³⁹ Hepatoma³⁹
BRCA2 ^b	Germline mutation^52,113 Breast and ovarian cancer Biallelic mutation¹ Leukemia Medulloblastoma, other solid tumors	Testicular tumors^93,99

MPNST, malignant peripheral nerve sheath tumor.

^aThe most commonly reported cancers are listed.

^bRarely inactivated by mutation in sporadic cancers.^89,109

Histologic features of these tumors are similar between mutant models. Neoplastic cells are typically spindloid to variably epithelioid with oval to tapered nuclei, and they are arranged in fascicles, stacks, and whorls (Fig. 5).^5,9,26,85 These highly invasive tumors can arise in any of 3 distinct sites: the retrobulbar region, the coelom, and the flank or tail.^9,26,85,99 Interestingly, MPNSTs in zebrafish are highly aneuploid and show nonrandom regions of chromosomal amplifications and losses, even when tumors are derived from different mutant zebrafish lines.¹¹⁸

Classification of these tumors as MPNSTs has been somewhat controversial, as these tumors reportedly do not express S100 or PGP9.5,⁸⁵ markers that have been used for identification of human MPNSTs.^30,41 However, the report that zebrafish MPNSTs do express glial fibrillary acidic protein (gfap) by RNA in situ hybridization⁹ supports a neural origin for these tumors, as human MPNST can be immunoreactive for GFAP.³⁰ The difficulty in classifying these malignant spindle cell tumors, as well as other tumors that arise in zebrafish cancer models, highlights the need for zebrafish-specific antibody panels that will complement histologic analyses.

In a forward genetic study, 4 mutant zebrafish lines (designated as Hagoromo mutants) derived from a retroviral insertional mutant library were susceptible to neuroblastoma-like tumors of the head.⁴ Heterozygous Hagoromo mutants developed expansile masses composed of small, ovoid cells in densely packed sheets with infrequent rosette formation; cells were positive for the pan-neural marker HuC.⁴ Juvenile Hagoromo mutants exhibited aberrant persistence of putative neural progenitor cells in cranial ganglia that were proposed to be a preneoplastic population.⁴ In all 4 lines, retroviral integration resulted in activation of an upstream gene, fibroblast growth factor 8 (fgf8).⁴ The role for fgf8 in neoplastic transformation or progression is unclear but may promote progenitor cell proliferation or survival.⁴

There are very few models for tumors of neuroendocrine origin in zebrafish (Table 6). A single zebrafish model for pituitary corticotroph adenoma has been described.⁶⁷ In this model, overexpression of the pituitary tumor transforming gene (pttg/securin) in cells of the adenohypophyseal proopiomelanocortin (POMC) lineage leads to formation of pituitary corticotroph adenomas in adult transgenic zebrafish.⁶⁷ Interestingly, adult transgenic zebrafish developed multiple signs of endocrine dysfunction, including hypercortisolemia, hyperplasia of renal steroidogenic cells, relative insulin resistance, hepatic lipidosis, and cardiomyopathy.⁶⁷ Tg(pomc-pttg) zebrafish embryos were successfully used to identify small-molecule inhibitors of pituitary POMC cell expansion, which were subsequently found to inhibit growth of neoplastic corticotrophs in vitro and in vivo.⁶⁷

A model for pancreatic neuroendocrine carcinoma in zebrafish has also been described, although a stable transgenic line has not yet been established (Table 6). Zebrafish that overexpressed MYCN in the pancreas developed invasive, insulin-expressing carcinomas, with neurosecretory granules identified in neoplastic cells by transmission electron microscopy, presumably reflecting malignant transformation of pancreatic β-cells.¹¹⁴

Much remains to be explored in the development of transgenic or mutant zebrafish models for tumors of neural and neuroendocrine origin. The development of reporter lines defining functional promoter regions for the neural-specific genes nestin and gfap ⁵⁵ will be useful tools for targeting gene expression to cells of the central nervous system. Although certain endocrine tissues are organized differently in the zebrafish,⁷¹ the success of the above models in recapitulating major features associated with the equivalent diseases in humans suggests that development of novel models for neuroendocrine neoplasia in zebrafish will be fruitful.

Models of Gonadal Neoplasia

There are a small number of zebrafish models for reproductive tumorigenesis, all of which show gonadal tumor susceptibility in males (Table 8). Gonadal tumors in male zebrafish have also been observed at variable frequency in several studies reporting a spectrum of tumor susceptibility.^73,98,105 In contrast, ovarian tumors are rarely reported in transgenic, mutant, or carcinogen-exposed female zebrafish.^73,77

Table 8.

Zebrafish Models of Gonadal Neoplasia.

Tumor Type	Gene(s)	Methodology
Seminoma³³	Tg(flck-TAg)	Zebrafish flck promoter-regulated expression of SV40 large T antigen
Seminoma^76,77	bmpr1bb^sw40/sw40	Identified from forward screen of ENU mutagenized collection
Testicular tumors⁹⁹	brca2^hg5/hg5	Identified from ENU mutagenized library
Testicular tumors⁹³	brca2 mutant ZM_00075660	Identified from retroviral insertional mutagenesis library

bmpr1bb, bone morphogenetic receptor, type 1bb; ENU, N-ethyl-N-nitrosourea; flck, fugu lymphocyte-specific protein tyrosine kinase.

Specific susceptibility to testicular germ cell tumors (seminomas) has been described in a transgenic zebrafish model³³ and in a mutant zebrafish line.⁷⁷ In tg(flck-TAg) zebrafish, off-target expression of the SV40 large T antigen by the fugu lymphocyte-specific protein tyrosine kinase (flck) promoter in the testis led to seminoma development in older adult males.³³ In comparison, zebrafish with a nonsense mutation in the type 1B bone morphogenetic protein receptor alk6b developed seminomas at a median age of 7 months.^76,77 Both tg(flck-TAg) and alk6b-mutant zebrafish showed variable degrees of differentiation in seminomas, ranging from tumors with clear spermatocytic differentiation to tumors composed of homogeneous sheets of undifferentiated neoplastic spermatogonia.^33,77 Interestingly, alk6b-mutant female zebrafish did not develop ovarian tumors spontaneously, although germ cell differentiation was markedly impaired.^76,77 Rare ovarian germ cell tumors occurred in alk6b-mutant female zebrafish after exposure to DMBA.⁷⁷ Undifferentiated human germ cell tumors showed loss of bone morphogenetic protein (BMP) signaling, suggesting that BMP signaling may influence germ cell differentiation and transformation in human and zebrafish gonads.⁷⁶

Testicular tumors have also been reported in 2 different zebrafish lines with mutations in brca2 (Table 8). In humans, carriers for pathologic BRCA2 mutations are at increased risk for tumors of reproductive organs (breast and ovary);^52,113 however, the specific association between BRCA2 mutation and reproductive tumorigenesis is not understood. In both brca2-mutant zebrafish lines, homozygous brca2 mutation led to an all-male phenotype characterized by arrested spermatogenesis.^93,99 Although the absence of brca2-homozygous female zebrafish impeded evaluation of ovarian cancer susceptibility, male brca2 homozygotes were susceptible to testicular neoplasia of both somatic and germ cell origin (Figure 6).^93,99 Zebrafish with combined mutations in brca2 and tp53 developed MPNSTs and other sarcomas in multiple tissues, and female zebrafish with these mutations showed an increased incidence of tumors arising in the ovary.^93,99 These studies provided new insight into the role for BRCA2 in reproductive development and demonstrate a conserved role for BRCA2 in reproductive tumorigenesis in humans and zebrafish.

Zebrafish Cancer Models: Future Directions

There are currently numerous undefined or underexplored areas for cancer research in zebrafish models, some of which have been noted in this review. Models for cancers of the brain, bone, and ovary remain to be developed; many other types of cancer models, including nonmelanoma cutaneous tumors, certain mesenchymal tumors, and endocrine tumors, are thus far quite limited. Although the absence of some tissue types in fish species, such as breast and prostate, limits the usefulness of zebrafish for investigating cancers of these organs, the zebrafish model has nonetheless become a powerful tool in comparative biomedical research. New methods for creating gene modifications or disruptions, such as zinc finger nucleases and transcription activator-like effector nucleases (TALENS), are being applied in zebrafish to generate targeted, heritable genetic mutations.^21,42,70,95 Recent technological advances for analyzing tumor development in zebrafish in vivo, including magnetic resonance imaging,⁴⁹ ultrasound biomicroscopy,³⁴ and high-throughput fluorescent macroscopic imaging,¹⁰¹ reflect the development and adaptation of increasingly sophisticated systems tailored to zebrafish research.

The successful development of numerous zebrafish models for human cancer clearly demonstrates that mechanisms for neoplastic transformation and tumor progression are conserved across relatively wide evolutionary distances. Although it is significant that many features of cancer development in zebrafish faithfully recapitulate important aspects of their human counterparts, the usefulness of zebrafish as a cancer model extends far beyond mere phenotypic or genotypic replication of disease. Multiple studies have shown that judicious and creative use of zebrafish cancer models can lead to important insights into disease pathogenesis and therapy. Such approaches may range from small-molecule chemical screens to high-throughput investigations of potential enhancer/repressor genes to transplantation or xenotransplantation experiments. A key strength of the zebrafish model in cancer research is the ability to seamlessly transition between embryonic and adult animal studies, providing coordinated exploration of critical developmental, transformative, and pathological events in vivo. These attributes ensure that zebrafish models for human cancer are here to stay.

Footnotes

Acknowledgements

The author thanks Dr Dennis Hickstein, Dr Robert West, and Ms Lisa Embree for critical review of the manuscript and Dr Leonard Zon, Dr Charles Kaufman, Dr Colleen Albacker, Dr Narie Storer, Dr Steven Leach, Dr Shu Liu, Dr David Langenau, and Dr Jessica Blackburn for contributions of histologic images.

Declaration of Conflicting Interests

The author declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

This work was supported by the Intramural Research Program of the US National Institutes of Health, National Cancer Institute, Center for Cancer Research.

References

Alter

Rosenberg

Brody

. Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2. J Med Genet. 2007;44:1–9.

Amatruda

Patton

. Genetic models of cancer in zebrafish. Int Rev Cell Mol Biol. 2008;271:1–34.

Amsterdam

Burgess

Golling

. A large-scale insertional mutagenesis screen in zebrafish. Genes Dev. 1999;13:2713–2724.

Amsterdam

Lai

Komisarczuk

. Zebrafish Hagoromo mutants up-regulate fgf8 postembryonically and develop neuroblastoma. Mol Cancer Res. 2009;7:841–850.

Amsterdam

Sadler

Lai

. Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol. 2004;2:E139.

Anelli

Santoriello

Distel

. Global repression of cancer gene expression in a zebrafish model of melanoma is linked to epigenetic regulation. Zebrafish. 2009;6:417–424.

Beckwith

Moore

Tsao-Wu

. Ethylnitrosourea induces neoplasia in zebrafish (Danio rerio). Lab Invest. 2000;80:379–385.

Bennett

Kanki

Rhodes

. Myelopoiesis in the zebrafish, Danio rerio. Blood. 2001;98:643–651.

Berghmans

Murphey

, Wienholds E, et al. tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. Proc Natl Acad Sci U S A. 2005;102:407–412.

10.

Bolli

Payne

Grabher

. Expression of the cytoplasmic NPM1 mutant (NPMc+) causes the expansion of hematopoietic cells in zebrafish. Blood. 2010;115:3329–3340.

11.

Bunton

. Experimental chemical carcinogenesis in fish. Toxicol Pathol. 1996;24:603–618.

12.

Ceol

Houvras

Jane-Valbuena

. The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset. Nature. 2011;471:513–517.

13.

Ceol

Houvras

White

. Melanoma biology and the promise of zebrafish. Zebrafish. 2008;5:247–255.

14.

Chen

Jette

Kanki

. NOTCH1-induced T-cell leukemia in transgenic zebrafish. Leukemia. 2007;21:462–471.

15.

Choorapoikayil

Kuiper

de Bruin

. Haploinsufficiency of the genes encoding the tumor suppressor Pten predisposes zebrafish to hemangiosarcoma. Dis Model Mech. 2012;5:241–247.

16.

Chu

Weiss

Modern immunohistochemistry. In: Cambridge Illustrated Surgical Pathology. New York: Cambridge University Press; 2009.

17.

Crowhurst

Layton

Lieschke

. Developmental biology of zebrafish myeloid cells. Int J Dev Biol. 2002;46:483–492.

18.

Culp

Nusslein-Volhard

Hopkins

. High-frequency germ-line transmission of plasmid DNA sequences injected into fertilized zebrafish eggs. Proc Natl Acad Sci U S A. 1991;88:7953–7957.

19.

Daniotti

Oggionni

Ranzani

. BRAF alterations are associated with complex mutational profiles in malignant melanoma. Oncogene. 2004;23:5968–5977.

20.

Dovey

White

Zon

. Oncogenic NRAS cooperates with p53 loss to generate melanoma in zebrafish. Zebrafish. 2009;6:397–404.

21.

Doyon

McCammon

Miller

. Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases. Nat Biotechnol. 2008;26:702–708.

22.

Eisinger

Nadauld

Shelton

. The adenomatous polyposis coli tumor suppressor gene regulates expression of cyclooxygenase-2 by a mechanism that involves retinoic acid. J Biol Chem. 2006;281:20474–20482.

23.

Eng

. PTEN: one gene, many syndromes. Hum Mutat. 2003;22:183–198.

24.

Faucherre

Taylor

Overvoorde

. Zebrafish pten genes have overlapping and non-redundant functions in tumorigenesis and embryonic development. Oncogene. 2008;27:1079–1086.

25.

Fearnhead

Britton

Bodmer

. The ABC of APC. Hum Mol Genet. 2001;10:721–733.

26.

Feitsma

Kuiper

Korving

. Zebrafish with mutations in mismatch repair genes develop neurofibromas and other tumors. Cancer Res. 2008;68:5059–5066.

27.

Feng

Langenau

Madge

. Heat-shock induction of T-cell lymphoma/leukaemia in conditional Cre/lox-regulated transgenic zebrafish. Br J Haematol. 2007;138:169–175.

28.

Feng

Stachura

White

. T-lymphoblastic lymphoma cells express high levels of BCL2, S1P1, and ICAM1, leading to a blockade of tumor cell intravasation. Cancer Cell. 2010;18:353–366.

29.

Ferrando

Neuberg

Staunton

. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell. 2002;1:75–87.

30.

Fletcher

CDM

. Diagnostic Histopathology of Tumors. 3rd ed. Philadelphia, PA: Churchill Livingstone Elsevier; 2007.

31.

Forrester

Grabher

McBride

. NUP98-HOXA9-transgenic zebrafish develop a myeloproliferative neoplasm and provide new insight into mechanisms of myeloid leukaemogenesis. Br J Haematol. 2011;155:167–181.

32.

Frazer

Meeker

Rudner

. Heritable T-cell malignancy models established in a zebrafish phenotypic screen. Leukemia. 2009;23:1825–1835.

33.

Gill

Lowe

Nguyen

. Enforced expression of Simian virus 40 large T-antigen leads to testicular germ cell tumors in zebrafish. Zebrafish. 2010;7:333–341.

34.

Goessling

North

Zon

. Ultrasound biomicroscopy permits in vivo characterization of zebrafish liver tumors. Nat Methods. 2007;4:551–553.

35.

Gomez

Volff

Hornung

. Identification of a second egfr gene in Xiphophorus uncovers an expansion of the epidermal growth factor receptor family in fish. Mol Biol Evol. 2004;21:266–275.

36.

Gray-Schopfer

Wellbrock

Marais

. Melanoma biology and new targeted therapy. Nature. 2007;445:851–857.

37.

Gutierrez

Grebliunaite

Feng

. Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia. J Exp Med. 2011;208:1595–1603.

38.

Gutierrez

Snyder

Marino-Enriquez

. Aberrant AKT activation drives well-differentiated liposarcoma. Proc Natl Acad Sci U S A. 2011;108:16386–16391.

39.

Haramis

Hurlstone

van der Velden

. Adenomatous polyposis coli-deficient zebrafish are susceptible to digestive tract neoplasia. EMBO Rep. 2006;7:444–449.

40.

Hirata

Nakamura

Kanemaru

. Pigment cell organization in the hypodermis of zebrafish. Dev Dyn. 2003;227:497–503.

41.

Hoang

Sinkre

Albores-Saavedra

. Expression of protein gene product 9.5 in epithelioid and conventional malignant peripheral nerve sheath tumors. Arch Pathol Lab Med. 2001;125:1321–1325.

42.

Huang

Xiao

Zhou

. Heritable gene targeting in zebrafish using customized TALENs. Nat Biotechnol. 2011;29:699–700.

43.

Huff

Cirvello

Haseman

Bucher

. Chemicals associated with site-specific neoplasia in 1394 long-term carcinogenesis experiments in laboratory rodents. Environ Health Perspect. 1991;93:247–270.

44.

Huff

Haseman

Rall

. Scientific concepts, value, and significance of chemical carcinogenesis studies. Annu Rev Pharmacol Toxicol. 1991;31:621–652.

45.

Hurlstone

Haramis

Wienholds

. The Wnt/beta-catenin pathway regulates cardiac valve formation. Nature. 2003;425:633–637.

46.

Jagadeeswaran

Sheehan

Craig

. Identification and characterization of zebrafish thrombocytes. Br J Haematol. 1999;107:731–738.

47.

Jessen

Vogel

. Concurrent expression of recombination activating genes 1 and 2 in zebrafish olfactory sensory neurons. Genesis. 2001;29:156–162.

48.

Spitsbergen

Eden

. Co-activation of hedgehog and AKT pathways promote tumorigenesis in zebrafish. Mol Cancer. 2009;8:40.

49.

Kabli

Spaink

. In vivo magnetic resonance imaging to detect malignant melanoma in adult zebrafish. Zebrafish. 2010;7:143–148.

50.

Kaufmann

Nevis

. Defective cell cycle checkpoint functions in melanoma are associated with altered patterns of gene expression. J Invest Dermatol. 2008;128:175–187.

51.

Kent

Bishop-Stewart

Matthews

. Pseudocapillaria tomentosa, a nematode pathogen, and associated neoplasms of zebrafish (Danio rerio) kept in research colonies. Comp Med. 2002;52:354–358.

52.

King

Marks

Mandell

. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 2003;302:643–646.

53.

Laale

. Biology and use of zebrafish, Brachydanio rerio in fisheries research: literature review. J Fish Biol. 1977;10:121–173.

54.

Lally

Geiger

Kridel

. Identification and biological evaluation of a novel and potent small molecule radiation sensitizer via an unbiased screen of a chemical library. Cancer Res. 2007;67:8791–8799.

55.

Lam

Marz

, Strahle U. gfap and nestin reporter lines reveal characteristics of neural progenitors in the adult zebrafish brain. Dev Dyn. 2009;238:475–486.

56.

Lam

Vega

. Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression. Nat Biotechnol. 2006;24:73–75.

57.

Langenau

Feng

Berghmans

. Cre/lox-regulated transgenic zebrafish model with conditional myc-induced T cell acute lymphoblastic leukemia. Proc Natl Acad Sci U S A. 2005;102:6068–6073.

58.

Langenau

Jette

Berghmans

. Suppression of apoptosis by bcl-2 overexpression in lymphoid cells of transgenic zebrafish. Blood. 2005;105:3278–3285.

59.

Langenau

Keefe

Storer

. Effects of RAS on the genesis of embryonal rhabdomyosarcoma. Genes Dev. 2007;21:1382–1395.

60.

Langenau

Traver

Ferrando

. Myc-induced T cell leukemia in transgenic zebrafish. Science. 2003;299:887–890.

61.

Langenau

Keefe

. Heat shock-inducible Cre/Lox approaches to induce diverse types of tumors and hyperplasia in transgenic zebrafish. Proc Natl Acad Sci U S A. 2007;104:9410–9415.

62.

Leacock

Basse

Chandler

. A zebrafish transgenic model of Ewing’s sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesis. Dis Model Mech. 2012;5:95–106.

63.

Huang

Zhan

. Inducible and repressable oncogene-addicted hepatocellular carcinoma in Tet-on xmrk transgenic zebrafish. J Hepatol. 2012;56:419–425.

64.

Lieschke

Currie

. Animal models of human disease: zebrafish swim into view. Nat Rev Genet. 2007;8:353–367.

65.

Lieschke

Oates

Crowhurst

. Morphologic and functional characterization of granulocytes and macrophages in embryonic and adult zebrafish. Blood. 2001;98:3087–3096.

66.

Lister

Raible

. Duplicate mitf genes in zebrafish: complementary expression and conservation of melanogenic potential. Dev Biol. 2001;237:333–344.

67.

Liu

Jiang

Ben-Shlomo

. Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor. Proc Natl Acad Sci U S A. 2011;108:8414–8419.

68.

Liu

Leach

. Screening pancreatic oncogenes in zebrafish using the Gal4/UAS system. Methods Cell Biol. 2011;105:367–381.

69.

Lynch

Lanspa

. Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet. 2009;76:1–18.

70.

Meng

Noyes

Zhu

. Targeted gene inactivation in zebrafish using engineered zinc-finger nucleases. Nat Biotechnol. 2008;26:695–701.

71.

Menke

Spitsbergen

Wolterbeek

. Normal anatomy and histology of the adult zebrafish. Toxicol Pathol. 2011;39:759–775.

72.

Michailidou

Jones

Walker

. Dissecting the roles of Raf- and PI3K-signalling pathways in melanoma formation and progression in a zebrafish model. Dis Model Mech. 2009;2:399–411.

73.

Moore

Rush

Breneman

. Zebrafish genomic instability mutants and cancer susceptibility. Genetics. 2006;174:585–600.

74.

Mullins

Hammerschmidt

Haffter

. Large-scale mutagenesis in the zebrafish: in search of genes controlling development in a vertebrate. Curr Biol. 1994;4:189–202.

75.

Murtha

Keller

. Hematologic and serum biochemical values for zebrafish (Danio rerio). Comp Med. 2003;53:37–41.

76.

Neumann

Chandler

Damoulis

. Mutation in the type IB bone morphogenetic protein receptor Alk6b impairs germ-cell differentiation and causes germ-cell tumors in zebrafish. Proc Natl Acad Sci U S A. 2011;108:13153–13158.

77.

Neumann

Dovey

Chandler

. Identification of a heritable model of testicular germ cell tumor in the zebrafish. Zebrafish. 2009;6:319–327.

78.

Nguyen

Emelyanov

Koh

. A high level of liver-specific expression of oncogenic Kras(V12) drives robust liver tumorigenesis in transgenic zebrafish. Dis Model Mech. 2011;4:801–813.

79.

Nguyen

Emelyanov

Koh

. An inducible kras(V12) transgenic zebrafish model for liver tumorigenesis and chemical drug screening. Dis Model Mech. 2012;5:63–72.

80.

Nicoli

Ribatti

Cotelli

. Mammalian tumor xenografts induce neovascularization in zebrafish embryos. Cancer Res. 2007;67:2927–2931.

81.

Oettinger

Schatz

Gorka

. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science. 1990;248:1517–1523.

82.

Olivier

Hollstein

Hainaut

TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol. 2010;2:a001008.

83.

Onnebo

Condron

McPhee

. Hematopoietic perturbation in zebrafish expressing a tel-jak2a fusion. Exp Hematol. 2005;33:182–188.

84.

Palmero

Achatz

Ashton-Prolla

. Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome. Curr Opin Oncol. 2010;22:64–69.

85.

Parant

George

Holden

. Genetic modeling of Li-Fraumeni syndrome in zebrafish. Dis Model Mech. 2010;3:45–56.

86.

Parichy

Rawls

Pratt

. Zebrafish sparse corresponds to an orthologue of c-kit and is required for the morphogenesis of a subpopulation of melanocytes, but is not essential for hematopoiesis or primordial germ cell development. Development. 1999;126:3425–3436.

87.

Park

Davison

Rhee

. Oncogenic KRAS induces progenitor cell expansion and malignant transformation in zebrafish exocrine pancreas. Gastroenterology. 2008;134:2080–2090.

88.

Patton

Widlund

Kutok

. BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr Biol. 2005;15:249–254.

89.

Peltomaki

. Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet. 2001;10:735–740.

90.

Phelps

Chidester

Dehghanizadeh

. A two-step model for colon adenoma initiation and progression caused by APC loss. Cell. 2009;137:623–634.

91.

Reischauer

Levesque

Nusslein-Volhard

. Lgl2 executes its function as a tumor suppressor by regulating ErbB signaling in the zebrafish epidermis. PLoS Genet. 2009;5:e1000720.

92.

Rhodes

Amsterdam

Sanda

. Emi1 maintains genomic integrity during zebrafish embryogenesis and cooperates with p53 in tumor suppression. Mol Cell Biol. 2009;29:5911–5922.

93.

Rodriguez-Mari

Wilson

Titus

. Roles of brca2 (fancd1) in oocyte nuclear architecture, gametogenesis, gonad tumors, and genome stability in zebrafish. PLoS Genet. 2011;7:e1001357.

94.

Sabaawy

Azuma

Embree

. TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia. Proc Natl Acad Sci U S A. 2006;103:15166–15171.

95.

Sander

Cade

Khayter

. Targeted gene disruption in somatic zebrafish cells using engineered TALENs. Nat Biotechnol. 2011;29:697–698.

96.

Santoriello

Gennaro

Anelli

. Kita driven expression of oncogenic HRAS leads to early onset and highly penetrant melanoma in zebrafish. PLoS One. 2010;5:e15170.

97.

Shepard

Amatruda

Finkelstein

. A mutation in separase causes genome instability and increased susceptibility to epithelial cancer. Genes Dev. 2007;21:55–59.

98.

Shepard

Amatruda

Stern

. A zebrafish bmyb mutation causes genome instability and increased cancer susceptibility. Proc Natl Acad Sci U S A. 2005;102:13194–13199.

99.

Shive

West

, Embree LJ, et al. brca2 in zebrafish ovarian development, spermatogenesis, and tumorigenesis. Proc Natl Acad Sci U S A. 2010;107:19350–19355.

100.

Sieber

Tomlinson

Lamlum

. The adenomatous polyposis coli (APC) tumour suppressor—genetics, function and disease. Mol Med Today. 2000;6:462–469.

101.

Smith

Raimondi

Salthouse

. High-throughput cell transplantation establishes that tumor-initiating cells are abundant in zebrafish T-cell acute lymphoblastic leukemia. Blood. 2010;115:3296–3303.

102.

Sonawane

Carpio

Geisler

. Zebrafish penner/lethal giant larvae 2 functions in hemidesmosome formation, maintenance of cellular morphology and growth regulation in the developing basal epidermis. Development. 2005;132:3255–3265.

103.

Sood

English

Jones

. Methods for reverse genetic screening in zebrafish by resequencing and TILLING. Methods. 2006;39:220–227.

104.

Spitsbergen

Kent

. The state of the art of the zebrafish model for toxicology and toxicologic pathology research—advantages and current limitations. Toxicol Pathol. 2003;31(suppl):62–87.

105.

Spitsbergen

Tsai

Reddy

. Neoplasia in zebrafish (Danio rerio) treated with N-methyl-N′-nitro-N-nitrosoguanidine by three exposure routes at different developmental stages. Toxicol Pathol. 2000;28:716–725.

106.

Sprague

Clements

Conlin

. The Zebrafish Information Network (ZFIN): the zebrafish model organism database. Nucleic Acids Res. 2003;31:241–243.

107.

Suster

Abe

Schouw

. Transposon-mediated BAC transgenesis in zebrafish. Nat Protoc. 2011;6:1998–2021.

108.

Thermes

Grabher

Ristoratore

. I-SceI meganuclease mediates highly efficient transgenesis in fish. Mech Dev. 2002;118:91–98.

109.

Turner

Tutt

Ashworth

. Hallmarks of ‘BRCAness’ in sporadic cancers. Nat Rev Cancer. 2004;4:814–819.

110.

White

Cech

Ratanasirintrawoot

. DHODH modulates transcriptional elongation in the neural crest and melanoma. Nature. 2011;471:518–522.

111.

Widlund

Fisher

. Microphthalamia-associated transcription factor: a critical regulator of pigment cell development and survival. Oncogene. 2003;22:3035–3041.

112.

Wimmer

Etzler

. Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg? Hum Genet. 2008;124:105–122.

113.

Wooster

Neuhausen

Mangion

. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science. 1994;265:2088–2090.

114.

Yang

Kutok

Lee

. Targeted expression of human MYCN selectively causes pancreatic neuroendocrine tumors in transgenic zebrafish. Cancer Res. 2004;64:7256–7262.

115.

Yang

Jiang

Chaichanasakul

. Modified bacterial artificial chromosomes for zebrafish transgenesis. Methods. 2006;39:183–188.

116.

Yeh

Munson

Chao

. AML1-ETO reprograms hematopoietic cell fate by downregulating scl expression. Development. 2008;135:401–410.

117.

Zarrin

Fong

Malkin

. Cloning and characterization of the human recombination activating gene 1 (RAG1) and RAG2 promoter regions. J Immunol. 1997;159:4382–4394.

118.

Zhang

Hoersch

Amsterdam

. Highly aneuploid zebrafish malignant peripheral nerve sheath tumors have genetic alterations similar to human cancers. Proc Natl Acad Sci U S A. 2010;107:16940–16945.

119.

Zhuravleva

Paggetti

Martin

. MOZ/TIF2-induced acute myeloid leukaemia in transgenic fish. Br J Haematol. 2008;143:378–382.

Zebrafish Models for Human Cancer

Abstract

Keywords

Mechanisms for Developing Cancer Models in Zebrafish

Models of Cutaneous Neoplasia

Models of Muscular, Adipocytic, and Vascular Neoplasia

Models of Intestinal, Hepatic, and Exocrine Pancreatic Neoplasia

Models of Hematopoietic and Lymphoid Neoplasia

Models of Neural and Neuroendocrine Neoplasia

Models of Gonadal Neoplasia

Zebrafish Cancer Models: Future Directions

Footnotes

Acknowledgements

Declaration of Conflicting Interests

Funding

References